1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
100.00%
Some net income increase while CRON.TO is negative at -598.28%. John Neff would see a short-term edge over the struggling competitor.
-100.00%
Negative yoy D&A while CRON.TO is 47.96%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
200.26%
Deferred tax of 200.26% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-100.00%
Both cut yoy SBC, with CRON.TO at -33.86%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
100.00%
Well above CRON.TO's 48.52% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
100.00%
AR growth while CRON.TO is negative at -126.55%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
100.00%
Some inventory rise while CRON.TO is negative at -211.83%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
100.00%
AP growth well above CRON.TO's 135.49%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-16.67%
Negative yoy usage while CRON.TO is 125.87%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1295.23%
Negative yoy while CRON.TO is 20671.90%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-15.34%
Negative yoy CFO while CRON.TO is 234.45%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
100.00%
CapEx growth well above CRON.TO's 74.85%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Negative yoy acquisition while CRON.TO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
100.00%
Purchases well above CRON.TO's 100.00%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
78.29%
Investing outflow well above CRON.TO's 98.22%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-16.32%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-32.23%
Negative yoy issuance while CRON.TO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.